The Marseille Cancer Research Center celebrates its 50th anniversary ! -

Sep 2019 Oncotarget

Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.


Chretien AS, Fauriat C, Orlanducci F, Rey J, Gautherot E, Granjeaud S, Demerle C, Hamel JF, Cerwenka A, von Strandmann EP, Ifrah N, Lacombe C, Cornillet-Lefebvre P, Delaunay J, Toubert A, Arnoulet C, Vey N, Olive D


[This corrects the article DOI: 10.18632/oncotarget.17747.].

Read the article